Case number 1:25-cv-00043
Acerta Pharma B.V. et al v. MSN Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 20, 2025 | 19 | NOTICE OF SUBSTITUTION OF COUNSEL re MSN Pharmaceuticals Inc.: Entry of appearance of attorney James S. Green, Jr. Attorney John C. Phillips, Jr. terminated. (Green, James) (Entered: 05/20/2025) (2) |
| May 20, 2025 | 20 | NOTICE OF SUBSTITUTION OF COUNSEL re MSN Pharmaceuticals Inc.: Entry of appearance of attorney James S. Green, Jr. Attorney Megan C. Haney terminated. (Green, James) (Entered: 05/20/2025) (2) |
| May 20, 2025 | 21 | NOTICE OF SUBSTITUTION OF COUNSEL re MSN Laboratories Pvt. Ltd.: Entry of appearance of attorney James S. Green, Jr. Attorney John C. Phillips, Jr. terminated. (Green, James) (Entered: 05/20/2025) (2) |
| May 20, 2025 | 22 | NOTICE OF SUBSTITUTION OF COUNSEL re MSN Laboratories Pvt. Ltd.: Entry of appearance of attorney James S. Green, Jr. Attorney Megan C. Haney terminated. (Green, James) (Entered: 05/20/2025) (2) |
| May 20, 2025 | 23 | NOTICE OF SUBSTITUTION OF COUNSEL re MSN Pharmaceuticals Inc.: Entry of appearance of attorney Robert Karl Hill. Attorney John C. Phillips, Jr. terminated. (Hill, Robert) (Entered: 05/20/2025) (2) |
| May 20, 2025 | 24 | NOTICE OF SUBSTITUTION OF COUNSEL re MSN Pharmaceuticals Inc.: Entry of appearance of attorney Robert Karl Hill. Attorney Megan C. Haney terminated. (Hill, Robert) (Entered: 05/20/2025) (2) |
| May 20, 2025 | 25 | NOTICE OF SUBSTITUTION OF COUNSEL re MSN Laboratories Pvt. Ltd.: Entry of appearance of attorney Robert Karl Hill. Attorney John C. Phillips, Jr. terminated. (Hill, Robert) (Entered: 05/20/2025) (2) |
| May 20, 2025 | 26 | NOTICE OF SUBSTITUTION OF COUNSEL re MSN Laboratories Pvt. Ltd.: Entry of appearance of attorney Robert Karl Hill. Attorney Megan C. Haney terminated. (Hill, Robert) (Entered: 05/20/2025) (2) |
| Apr 16, 2025 | 18 | ***ALL PAPER'S SHALL BE FILED IN THE LEAD CASE***ORDER re (17 in 1:25-cv-00043-GBW) Stipulation filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, AstraZeneca AB, Acerta Pharma B.V., ORDER, Setting Deadlines/Hearings ( Fact Discovery completed by 2/13/2026., Reply Expert Reports due by 8/14/2026., A Five- Day Bench Trial is set for 4/26/2027 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams., A Final Pretrial Conference is set for 4/20/2027 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams., A Markman Hearing is set for 10/28/2025 at 02:00 PM in Courtroom 6B before Judge Gregory B. Williams. Signed by Judge Gregory B. Williams on 4/16/2025. Associated Cases: 1:24-cv-00587-GBW, 1:25-cv-00043-GBW(lnb) (Entered: 04/16/2025) (6) |
| Apr 16, 2025 | N/A | Cases associated with lead case 24-587. Signed by Judge Gregory B. Williams on 4/16/2025. (lnb) (Entered: 04/16/2025) (0) |
| Apr 7, 2025 | 17 | STIPULATION and [Proposed] Order Regarding Consolidation and Amended Case Schedule by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Joyce, Alexandra) (Entered: 04/07/2025) (6) |
| Apr 4, 2025 | 16 | ANSWER to 9 Answer to Complaint, Counterclaim by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited.(Silver, Daniel) (Entered: 04/04/2025) (7) |
| Mar 24, 2025 | N/A | SO ORDERED, re 12 MOTION for Pro Hac Vice Appearance of Attorney Richard J. Berman, Janine A. Carlan, Bradford C. Frese and Saukshmya Trichi filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc. Signed by Judge Gregory B. Williams on 3/24/25. (jaa) (Entered: 03/24/2025) (0) |
| Mar 24, 2025 | N/A | Pro Hac Vice Attorney Richard J. Berman,Janine A. Carlan,Bradford C. Frese,Saukshmya Trichi for MSN Laboratories Pvt. Ltd.,Richard J. Berman,Janine A. Carlan,Bradford C. Frese,Saukshmya Trichi for MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs) (Entered: 03/24/2025) (0) |
| Mar 21, 2025 | 12 | MOTION for Pro Hac Vice Appearance of Attorney Richard J. Berman, Janine A. Carlan, Bradford C. Frese and Saukshmya Trichi - filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Attachments: # 1 Certification of Richard J. Berman, # 2 Certification of Janine A. Carlan, # 3 Certification of Bradford C. Frese, # 4 Certification of Saukshmya Trichi)(Haney, Megan) (Entered: 03/21/2025) (0) |
| Mar 21, 2025 | 13 | Pro Hac Vice Fee - Credit Card Payment received for Richard J. Berman, Janine A. Carlan, Bradford C. Frese, and Saukshmya Trichi. ( re 12 MOTION for Pro Hac Vice Appearance of Attorney Richard J. Berman, Janine A. Carlan, Bradford C. Frese and Saukshmya Trichi )( Payment of $ 200, receipt number ADEDC-4642896).(Haney, Megan) (Entered: 03/21/2025) (0) |
| Mar 21, 2025 | 14 | NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery, (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 4(a) of the Delaware Default Standard for Discovery, and (3) Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited.(Silver, Daniel) (Entered: 03/21/2025) (2) |
| Mar 21, 2025 | 15 | NOTICE OF SERVICE of Defendants MSN Pharmaceuticals Inc.'s and MSN Laboratories Private Limited's Rule 26(a)(1) Initial Disclosures and Defendants MSN Pharmaceuticals Inc.'s and MSN Laboratories Private Limited's Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard Discovery filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Haney, Megan) (Entered: 03/21/2025) (2) |
| Mar 17, 2025 | 11 | NOTICE of Appearance by Megan C. Haney on behalf of MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc. (Haney, Megan) (Entered: 03/17/2025) (1) |
| Mar 14, 2025 | 9 | ANSWER to 1 Complaint, , COUNTERCLAIM against Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited by MSN Pharmaceuticals Inc., MSN Laboratories Pvt. Ltd..(Phillips, John) (Entered: 03/14/2025) (30) |
| Mar 14, 2025 | 10 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Limited for MSN Pharmaceuticals Inc. filed by MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Phillips, John) (Entered: 03/14/2025) (3) |
| Jan 17, 2025 | 7 | WAIVER OF SERVICE returned executed by AstraZeneca UK Limited, Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca AB: For MSN Laboratories Pvt. Ltd. waiver sent on 1/13/2025, answer due 3/14/2025. (Joyce, Alexandra) (Entered: 01/17/2025) (1) |
| Jan 17, 2025 | 8 | WAIVER OF SERVICE returned executed by AstraZeneca UK Limited, Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca AB: For MSN Pharmaceuticals Inc. waiver sent on 1/13/2025, answer due 3/14/2025. (Joyce, Alexandra) (Entered: 01/17/2025) (1) |
| Jan 15, 2025 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 01/15/2025) (0) |
| Jan 10, 2025 | 1 | Complaint* (1) |
| Jan 10, 2025 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 01/10/2025) (3) |
| Jan 10, 2025 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/27/2024. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 5/27/2027. (oam) (Entered: 01/10/2025) (2) |
| Jan 10, 2025 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,272,083; 11,059,829. (oam) (Entered: 01/10/2025) (1) |
| Jan 10, 2025 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited filed by AstraZeneca AB, Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP. (oam) (Entered: 01/10/2025) (2) |
| Jan 10, 2025 | 6 | Summons Issued as to MSN Laboratories Pvt. Ltd. on 1/10/2025; MSN Pharmaceuticals Inc. on 1/10/2025. (Attachments: # 1 Summons Issued)(oam) (Entered: 01/10/2025) (0) |
